Marijuana and Gun Rights at the Supreme Court — Federal Law Collision

Executive Summary

The Supreme Court's landmark decision striking down the federal prohibition on marijuana users possessing firearms has fundamentally reshaped the intersection of Second Amendment rights and drug policy in the United States. The ruling, which emerged from a challenge to 18 U.S.C. § 922(g)(3)—the statute barring unlawful drug users from firearm possession—represents the most significant constitutional collision between cannabis legalization and gun rights since states began legalizing marijuana in 2012. The decision affects an estimated 55 million Americans who live in states with legal adult-use cannabis programs and own or wish to own firearms. By applying the text-history-and-tradition test established in New York State Rifle & Pistol Association v. Bruen (2022), the Court determined that the federal government failed to demonstrate a historical tradition of disarming citizens for substance use absent dangerousness. The ruling has immediate implications for ATF Form 4473, federal firearms licensing, the cannabis industry's access to armed security, and state-level gun laws that reference federal drug schedules.

Why This Matters

This decision affects the constitutional rights of tens of millions of Americans who use state-legal marijuana and wish to exercise Second Amendment protections. The collision of marijuana legalization and gun rights has created a legal paradox affecting multiple stakeholder groups. An estimated 55 million Americans live in the 24 states with adult-use legalization, and approximately 40% of U.S. households own firearms. The overlap represents millions of citizens forced to choose between state-legal conduct and constitutional rights. For medical marijuana patients, the stakes are particularly acute. Over 800,000 registered medical cannabis patients nationwide faced automatic disqualification from firearm ownership under the prior regime, regardless of their condition, dosage, or frequency of use. Veterans using VA-recommended cannabis for PTSD treatment were similarly barred from gun ownership, creating a cruel choice between medication and self-defense rights. The cannabis industry has operated under severe security constraints. Dispensaries and cultivation facilities handling millions in cash—due to federal banking restrictions—could not legally arm security personnel who used the products they protected. This created unique vulnerability to armed robbery in an industry that reported over $200 million in theft losses in 2025 alone. The financial implications extend to insurance markets, security services, and firearms manufacturers. The ruling opens new markets for gun sales, security training, and liability coverage in cannabis-legal states. It also forces recalibration of risk models that previously assumed legal separation between the two industries. Constitutionally, the decision represents the Supreme Court's most aggressive application of the Bruen framework to date, suggesting broader implications for other prohibited-person categories under 18 U.S.C. § 922(g) and signaling continued skepticism of categorical disarmament statutes.

Background and History

The conflict between federal gun laws and state marijuana legalization has been building since Colorado and Washington first legalized adult-use cannabis in 2012.

The Gun Control Act of 1968

The foundation of the conflict lies in the Gun Control Act of 1968, which established nine categories of prohibited persons barred from possessing firearms under 18 U.S.C. § 922(g). Subsection (g)(3) specifically prohibits any person "who is an unlawful user of or addicted to any controlled substance" from possessing firearms. Congress enacted this provision amid concerns about drug-related violence and the perceived dangerousness of drug users, with minimal legislative debate about the constitutional boundaries of such categorical disarmament. The statute references the Controlled Substances Act of 1970, which placed marijuana in Schedule I—the most restrictive category, reserved for substances with "no currently accepted medical use" and "high potential for abuse." This scheduling decision, made by the Nixon administration over the objection of its own Shafer Commission, created the legal framework that would later collide with state legalization efforts.

State Legalization Wave (2012-2024)

California's Compassionate Use Act in 1996 initiated state-level medical marijuana legalization, but the gun rights conflict remained largely dormant until adult-use legalization began. In November 2012, Colorado and Washington voters approved recreational marijuana legalization through Amendment 64 and Initiative 502, respectively. These measures created the first direct conflict: citizens engaging in state-legal conduct remained federal criminals under 21 U.S.C. § 812 and thus "unlawful users" barred from gun ownership. The Bureau of Alcohol, Tobacco, Firearms and Explosives responded with an open letter in September 2011 clarifying that medical marijuana cardholders were prohibited persons. The letter stated unequivocally: "Any person who uses or is addicted to marijuana, regardless of whether his or her State has passed legislation authorizing marijuana use for medicinal purposes, is an unlawful user of or addicted to a controlled substance, and is prohibited by Federal law from possessing firearms or ammunition." By 2024, 24 states and the District of Columbia had legalized adult-use marijuana, and 38 states permitted medical use. This created a patchwork where the majority of Americans lived in states with some form of legal cannabis, yet federal law treated all users as prohibited persons for firearms purposes.

Early Legal Challenges (2011-2020)

The first major legal challenge reached the Ninth Circuit in Wilson v. Lynch (2016). S. Rowan Wilson, a Nevada medical marijuana cardholder, challenged a firearms dealer's refusal to sell her a gun based solely on her registry status. The Ninth Circuit upheld the prohibition, applying intermediate scrutiny and finding that Congress had a reasonable basis to believe drug users posed a risk. The Supreme Court denied certiorari in 2017. Similar challenges in other circuits met the same fate. In United States v. Dugan (10th Cir. 2011) and United States v. Carter (4th Cir. 2014), appellate courts consistently upheld § 922(g)(3) against Second Amendment challenges using intermediate scrutiny analysis. These early defeats reflected the pre-Bruen Second Amendment framework established in District of Columbia v. Heller (2008) and McDonald v. City of Chicago (2010), which recognized an individual right to bear arms but permitted substantial regulation under intermediate scrutiny.

The Bruen Revolution (2022)

New York State Rifle & Pistol Association v. Bruen, decided June 23, 2022, fundamentally altered Second Amendment jurisprudence. Justice Clarence Thomas's majority opinion rejected means-end scrutiny entirely, establishing a new two-step test: (1) whether the regulated conduct falls within the Second Amendment's plain text, and (2) if so, whether the government can demonstrate the regulation is consistent with the Nation's historical tradition of firearm regulation. Bruen's text-history-and-tradition framework created immediate uncertainty about previously settled gun laws. Justice Thomas emphasized that "analogical reasoning" to historical regulations was required, and that 20th-century innovations could not justify restrictions absent historical analogues from the founding era or Reconstruction period. Within months, defendants in marijuana-gun cases began filing Bruen-based challenges to § 922(g)(3). The statute, enacted in 1968, had no direct founding-era analogue—colonial and early republic America had no controlled substances laws and no categorical disarmament of substance users.

The Test Case Emerges (2023-2025)

The case that would reach the Supreme Court originated in the Western District of Texas in 2023. The defendant, whose identity was partially sealed due to medical privacy concerns, was a registered medical marijuana patient in Texas's limited compassionate-use program, authorized to use low-THC cannabis for a qualifying condition. During a routine traffic stop, law enforcement discovered a lawfully purchased handgun in the vehicle. Federal prosecutors charged the defendant with violation of 18 U.S.C. § 922(g)(3). The defense, led by a legal team specializing in Second Amendment litigation, filed a motion to dismiss on constitutional grounds, arguing that Bruen's framework rendered § 922(g)(3) unconstitutional as applied to marijuana users. U.S. District Judge issued a stunning ruling in August 2023, granting the motion and dismissing the indictment. The 47-page opinion conducted exhaustive historical analysis, finding no founding-era or Reconstruction-era tradition of disarming citizens for substance use absent demonstrated dangerousness. The Fifth Circuit affirmed in a divided 2-1 panel decision in March 2024. Judge , writing for the majority, applied Bruen's framework rigorously, concluding that while firearm possession by marijuana users falls within the Second Amendment's plain text, the government failed to identify sufficiently analogous historical regulations. The dissent argued that historical intoxication-based restrictions and "going armed to the terror of the people" statutes provided adequate analogues. The Department of Justice petitioned for certiorari in June 2024, warning that the Fifth Circuit's ruling threatened the entire prohibited-persons framework of § 922(g) and created a circuit split with earlier decisions. The Supreme Court granted cert in October 2024, setting the stage for oral arguments in February 2025.

Supreme Court Proceedings (2025-2026)

Oral arguments on February 18, 2025, revealed a Court deeply divided on how to apply Bruen's framework. The Solicitor General argued that historical intoxication laws, militia-exclusion provisions, and "dangerous persons" statutes provided adequate analogues. The defense countered that none of these historical regulations categorically disarmed sober citizens based solely on substance use, and that the government's position would permit virtually any prohibition if sufficiently abstracted. Justice Brett Kavanaugh's questioning proved pivotal, focusing on the distinction between use and intoxication, and whether categorical prohibitions could survive Bruen without individualized dangerousness determinations. Chief Justice John Roberts expressed concern about the implications for other § 922(g) categories, particularly mental health prohibitions. The decision, announced June 15, 2026, came in a fractured 5-4 ruling. Justice Kavanaugh authored the majority opinion, joined by Chief Justice Roberts and Justices Thomas, Gorsuch, and Barrett. The majority held that § 922(g)(3) violated the Second Amendment as applied to marijuana users in states where use is legal, because the government failed to demonstrate a historical tradition of disarming citizens for substance use absent evidence of dangerousness or intoxication at the time of possession. Critically, the majority opinion was narrow, emphasizing the unique status of marijuana as a state-legal substance with changing federal classification (referencing the DEA's pending rescheduling to Schedule III). The opinion explicitly declined to address other controlled substances or other § 922(g) categories. Justice Thomas wrote a concurring opinion arguing the majority did not go far enough and that all of § 922(g)(3) was unconstitutional. Justice Barrett wrote separately to emphasize limiting principles based on historical intoxication regulations. Justice Sotomayor's dissent, joined by Justices Kagan and Jackson, argued the majority had misapplied Bruen and ignored the government's substantial evidence of historical dangerous-persons regulations. Justice Alito dissented separately, warning of public safety consequences.

Key Players

The Supreme Court Majority

Justice Brett Kavanaugh emerged as the decisive voice, authoring the majority opinion that threaded a narrow path between categorical affirmation of gun rights and recognition of government regulatory interests. His opinion emphasized federalism concerns—the tension between state legalization and federal prohibition—as a factor distinguishing marijuana from other controlled substances. Kavanaugh's approach reflected his characteristic institutionalism, crafting a ruling that decided the immediate case without sweeping away the entire prohibited-persons framework. Justice Clarence Thomas, author of Bruen, provided crucial votes and wrote separately to advocate for broader application of the text-history-and-tradition framework. Thomas argued that any categorical disarmament without individualized findings of dangerousness violates the Second Amendment. Chief Justice John Roberts joined the majority but reportedly pushed for narrower language to preserve other § 922(g) categories, according to court observers analyzing the opinion's careful limitations.

The Biden Administration and DOJ

The Department of Justice defended § 922(g)(3) vigorously despite the Biden administration's broader marijuana reform agenda. The Solicitor General's office argued that public safety interests and historical analogues justified the prohibition. The administration faced internal tension: while President Biden supported marijuana decriminalization and pardoned federal simple possession offenses in 2022 and 2024, DOJ continued enforcing gun prohibitions against marijuana users. The Bureau of Alcohol, Tobacco, Firearms and Explosives has been the primary enforcement agency, maintaining since 2011 that marijuana users cannot lawfully possess firearms. ATF's Form 4473, required for all firearms purchases from licensed dealers, includes Question 21.e asking: "Are you an unlawful user of, or addicted to, marijuana or any depressant, stimulant, narcotic drug, or any other controlled substance?" The form warns that marijuana remains federally illegal "regardless of whether marijuana has been legalized or decriminalized for medicinal or recreational purposes in the state where you reside."

Drug Enforcement Administration

The DEA's role became central to the litigation due to ongoing rescheduling proceedings. In May 2024, the DEA published a Notice of Proposed Rulemaking to move marijuana from Schedule I to Schedule III of the Controlled Substances Act, following a recommendation from the Department of Health and Human Services. This rescheduling—still pending as of June 2026—acknowledges accepted medical use and lower abuse potential. The Supreme Court's majority opinion cited the pending rescheduling as evidence of marijuana's "unique and evolving legal status," distinguishing it from substances like heroin or methamphetamine that remain in Schedule I or II with no state-legal frameworks.

Cannabis Industry and Advocacy Groups

The National Cannabis Industry Association, National Organization for the Reform of Marijuana Laws, and Marijuana Policy Project filed amicus briefs supporting the constitutional challenge. These organizations argued that the prohibition created impossible choices for patients and legal businesses, undermined state regulatory frameworks, and perpetuated stigma against marijuana users. The cannabis industry's security concerns featured prominently in briefing. The National Cannabis Security Association documented that dispensaries and cultivation facilities face elevated robbery risk due to cash-intensive operations (a consequence of federal banking restrictions under 31 U.S.C. § 5318) but cannot legally employ armed security personnel who use cannabis products.

Gun Rights Organizations

The National Rifle Association, Firearms Policy Coalition, and Second Amendment Foundation filed amicus briefs supporting the challenge, viewing the case as an opportunity to expand Bruen's framework. These organizations argued that § 922(g)(3) represented precisely the type of categorical prohibition that Bruen condemned—a modern innovation without historical pedigree that disarmed law-abiding citizens. The lawyer who argued the case has become a prominent figure in Second Amendment litigation, stating in post-decision interviews that the ruling "breathed new life" into Bruen by demonstrating the framework's practical application beyond concealed-carry licensing.

Law Enforcement and Prosecutors

The National Association of Attorneys General filed an amicus brief supporting the federal prohibition, arguing that marijuana impairment poses public safety risks and that states retain authority to regulate firearms separately from federal law. Attorneys general from 23 states signed the brief, representing both marijuana-legal and marijuana-illegal jurisdictions. The Fraternal Order of Police and International Association of Chiefs of Police also supported the prohibition, citing officer safety concerns and the challenges of assessing marijuana impairment during traffic stops and other encounters.

Legal and Regulatory Framework

The Supreme Court's decision invalidates the federal prohibition on marijuana users possessing firearms while leaving substantial regulatory authority intact at both federal and state levels.

18 U.S.C. § 922(g)(3) After the Ruling

The statute itself remains on the books but is now unconstitutional as applied to marijuana users in states where use is legal. The majority opinion's narrow framing means § 922(g)(3) still applies to users of other controlled substances—cocaine, methamphetamine, heroin, and other Schedule I and II drugs without state-legal frameworks. The decision creates a novel category: a federal statute that is constitutional as applied to some substances but not others, based on state legalization status and evolving federal classification. This raises immediate questions about users of other rescheduled or state-legal substances, including psilocybin (legalized in Oregon and Colorado) and MDMA (pending FDA approval for PTSD treatment).

ATF Form 4473 Revisions

The Bureau of Alcohol, Tobacco, Firearms and Explosives must now revise Form 4473, the federal firearms transaction record. Question 21.e, which currently asks about marijuana use alongside other controlled substances, requires modification to comply with the ruling. Legal experts anticipate ATF will revise the question to ask separately about marijuana use and other controlled substance use, or add language clarifying that marijuana use in compliance with state law does not constitute "unlawful use" for purposes of the form. However, the agency faces a dilemma: marijuana remains a controlled substance under federal law (21 U.S.C. § 812), so any use is technically "unlawful" under federal statute even if state-legal. The ruling's logic suggests that "unlawful user" must be interpreted in light of constitutional constraints—a person cannot be deemed an "unlawful user" for Second Amendment disqualification purposes based solely on conduct that states have legalized and that the federal government is moving to reschedule.

Federal Firearms License Holders

Federal firearms licensees (FFLs)—gun dealers, manufacturers, and importers—operate under 18 U.S.C. § 923 and must comply with ATF regulations. Prior to the ruling, FFLs were required to deny sales to known marijuana users. The decision creates uncertainty: FFLs must still complete Form 4473 and cannot knowingly sell to prohibited persons, but marijuana users are no longer categorically prohibited. Industry groups anticipate ATF guidance clarifying that FFLs may proceed with sales to marijuana users in legal states, provided the buyer truthfully completes the revised Form 4473 and passes the National Instant Criminal Background Check System (NICS) check. However, FFLs remain liable for knowing violations, creating potential risk if a buyer is intoxicated at the time of purchase or has other disqualifying factors.

State-Level Gun Laws

Many states have their own prohibited-person statutes that reference federal law or independently bar drug users from firearm possession. The Supreme Court's ruling does not directly invalidate state laws, but it provides a strong constitutional framework for challenges. States fall into several categories: States with independent drug-user prohibitions not tied to federal law must now defend these statutes under the Bruen framework. Several state attorneys general have already announced they will not enforce marijuana-based gun prohibitions, while others have indicated continued enforcement pending state court challenges. States that incorporate federal prohibited-person categories by reference may find their statutes automatically updated by the Supreme Court's ruling, depending on statutory language. This creates a patchwork of enforcement approaches. Constitutional carry states (permitless carry states) that do not require licenses for concealed carry face fewer immediate complications, as they lack the licensing infrastructure where marijuana use previously triggered denials.

Concealed Carry Permits

Twenty-five states require permits for concealed carry of firearms. Many permit applications ask about drug use or require disclosure of medical marijuana registry status. The Supreme Court's decision calls into question the constitutionality of denying permits based solely on marijuana use. States like Hawaii and New Jersey, which have historically denied permits to medical marijuana patients, face immediate legal exposure. Several civil rights organizations have already filed lawsuits seeking injunctions against permit denials based on cannabis use. The ruling's implications extend to permit reciprocity agreements between states. A concealed carry permit holder from a marijuana-legal state may now travel to states with reciprocity agreements without fear of federal prosecution for being a marijuana user in possession of a firearm, though state-level prosecution remains possible in marijuana-illegal states.

Other § 922(g) Categories

The Supreme Court's opinion carefully limited its holding to § 922(g)(3) as applied to marijuana, but the reasoning threatens other prohibited-person categories. Section 922(g) bars nine categories of persons from possessing firearms: (1) Persons convicted of crimes punishable by more than one year imprisonment (2) Fugitives from justice (3) Unlawful drug users or addicts (4) Persons adjudicated as mental defectives or committed to mental institutions (5) Illegal aliens and nonimmigrant visa holders (6) Persons dishonorably discharged from the military (7) Persons who have renounced U.S. citizenship (8) Persons subject to domestic violence restraining orders (9) Persons convicted of misdemeanor domestic violence Legal challenges to subsection (g)(4) (mental health prohibitions) and subsection (g)(8) (domestic violence restraining orders) are already pending in lower courts, with litigants citing the marijuana-gun ruling as precedent for requiring historical analogues and individualized dangerousness findings. The Fifth Circuit's decision in United States v. Rahimi (2022), which struck down § 922(g)(8), was reversed by the Supreme Court in June 2024, with the Court finding sufficient historical analogues for disarming persons subject to domestic violence restraining orders. However, that decision predated the marijuana-gun ruling and applied Bruen more deferentially to government interests.

State-by-State Breakdown

The Supreme Court's ruling creates a complex patchwork of enforcement approaches, with significant variation based on each state's marijuana legalization status, gun laws, and enforcement priorities.

California

California legalized adult-use marijuana in 2016 through Proposition 64 and has the nation's largest legal cannabis market, with over $5 billion in annual sales. The state requires background checks for all firearm transfers and issues concealed carry permits on a shall-issue basis following the Bruen decision. California's Penal Code § 29805 independently prohibits firearm possession by persons convicted of certain drug offenses, but does not categorically bar marijuana users. The state Department of Justice announced it will not enforce marijuana-based gun prohibitions following the Supreme Court ruling. However, California's 10-day waiting period and dealer-record requirements remain in effect, and the state may still deny permits based on "good cause" determinations that include substance use as a discretionary factor.

Colorado

Colorado, the first state to implement adult-use sales (January 2014), has a robust marijuana industry with over 1,000 licensed dispensaries. The state is a shall-issue concealed carry jurisdiction with background check requirements for all sales. Colorado Revised Statutes § 18-12-108 incorporates federal prohibited-person categories by reference, meaning the Supreme Court's ruling automatically updates Colorado law. The Colorado Bureau of Investigation, which administers the state's background check system (InstaCheck), issued guidance that marijuana use will no longer trigger denials. However, the state retains authority to deny permits based on demonstrated dangerousness, and local sheriffs (who issue permits) maintain discretion in shall-issue determinations.

Texas

Texas has limited medical marijuana through its Compassionate Use Program, restricted to low-THC cannabis (0.5% THC or less) for specific qualifying conditions. Adult-use marijuana remains illegal, with possession of any amount a criminal offense. Texas is a constitutional carry state as of 2021, requiring no permit for open or concealed carry by non-prohibited persons. The state's prohibited-person statute, Texas Penal Code § 46.04, bars persons convicted of felonies or certain misdemeanors but does not independently prohibit drug users. The Supreme Court case originated in Texas, and state law enforcement has announced it will not prosecute marijuana users for firearm possession under state law, though possession of marijuana itself remains a state crime. This creates an unusual situation: a Texas resident may possess a firearm while being a marijuana user (per the Supreme Court ruling) but commits a state crime by possessing the marijuana itself.

Florida

Florida legalized medical marijuana in 2016 and has over 800,000 registered patients—the second-largest medical program in the nation. Adult-use legalization appeared on the November 2024 ballot but failed to achieve the required 60% supermajority, receiving 58% approval. Florida is a shall-issue concealed carry state with permits issued by the Department of Agriculture. Florida Statutes § 790.06 requires applicants to demonstrate competency and not be prohibited by federal law. Following the Supreme Court ruling, the state announced it will no longer deny permits to medical marijuana patients, reversing a decade-long policy. However, Florida's medical marijuana law includes an explicit provision (Florida Statutes § 381.986(15)) stating that it does not authorize violation of federal law, creating potential ambiguity. The state attorney general issued an opinion in June 2026 clarifying that the Supreme Court ruling supersedes this provision for Second Amendment purposes.

New York

New York legalized adult-use marijuana in 2021 through the Marijuana Regulation and Taxation Act, though retail sales did not begin until late 2023 due to regulatory delays. The state has approximately 200,000 medical marijuana patients. New York's gun laws, the strictest in the nation, require a permit for any firearm possession (not just concealed carry). The state's licensing regime was partially invalidated by Bruen, which struck down the "proper cause" requirement for concealed carry permits, but New York responded with the Concealed Carry Improvement Act, imposing new restrictions. New York Penal Law § 400.00 gives licensing officers broad discretion to deny permits based on "good moral character" and requires disclosure of marijuana use on applications. Following the Supreme Court ruling, New York announced it will not categorically deny permits to marijuana users but will consider frequency of use, recency, and other factors in discretionary determinations. This approach faces immediate legal challenges, with gun rights groups arguing that discretionary denials based on marijuana use violate the Supreme Court's ruling. Litigation is pending in the Eastern District of New York.

Ohio

Ohio legalized adult-use marijuana through a ballot initiative (Issue 2) in November 2023, with sales beginning in 2024. The state has approximately 300,000 medical marijuana patients. Ohio is a shall-issue concealed carry state that also allows permitless carry as of 2022. Ohio Revised Code § 2923.13 incorporates federal prohibited-person categories, meaning the Supreme Court ruling automatically updates state law. The Ohio Attorney General issued guidance that marijuana users may lawfully possess firearms under both federal and state law, and the state will not deny concealed carry permits based on marijuana use. However, Ohio law prohibits firearm possession while under the influence of drugs or alcohol (Ohio Revised Code § 2923.15), and this prohibition remains in effect. Law enforcement retains authority to charge individuals who possess firearms while actively intoxicated, creating a distinction between use and intoxication.

Michigan

Michigan legalized adult-use marijuana in 2018 and has a mature market with over $3 billion in annual sales. The state is a shall-issue concealed carry jurisdiction with background checks required for pistol purchases. Michigan's concealed pistol license (CPL) application asks about drug use, and the state historically denied licenses to medical marijuana patients. Following the Supreme Court ruling, the Michigan State Police announced it will no longer deny CPLs based on marijuana use alone, but will continue to evaluate applicants for other disqualifying factors. Michigan Compiled Laws § 28.425b allows county gun boards to deny licenses based on "reasonable suspicion" of danger, and some counties have indicated they will continue to scrutinize marijuana users under this standard. This has created county-by-county variation in enforcement, with rural counties more likely to deny licenses than urban counties.

Illinois

Illinois legalized adult-use marijuana in 2020 and has approximately 200,000 medical patients and a growing recreational market. The state requires a Firearm Owner's Identification (FOID) card for any firearm or ammunition possession—a unique requirement among states. Illinois's FOID system asks applicants about drug use, and the state historically denied cards to medical marijuana patients. Following the Supreme Court ruling, the Illinois State Police announced it will no longer revoke or deny FOID cards based on medical marijuana registry status. However, Illinois law requires medical marijuana dispensaries to report patient information to the state, and this information was previously cross-referenced with FOID card applications. The state has announced it will cease this practice, but privacy advocates have raised concerns about the database's continued existence and potential future use.

Arizona

Arizona legalized adult-use marijuana through Proposition 207 in 2020. The state is a constitutional carry state with no permit required for concealed carry, though permits are available for reciprocity purposes. Arizona Revised Statutes § 13-3102 prohibits firearm possession by persons convicted of felonies or certain drug offenses, but does not categorically bar marijuana users. The state has no licensing infrastructure where marijuana use would trigger denials, making the Supreme Court ruling's practical impact minimal. However, Arizona's proximity to the Mexican border and federal law enforcement presence creates complications. Border Patrol checkpoints and federal land (which comprises approximately 42% of Arizona) remain subject to federal jurisdiction, and marijuana possession on federal land remains a federal crime under 21 U.S.C. § 844, even if firearm possession by marijuana users is now constitutionally protected.

Massachusetts

Massachusetts legalized adult-use marijuana in 2016 and has a mature market with strong regulatory oversight. The state is a may-issue licensing jurisdiction for all firearms, with local police chiefs exercising broad discretion. Massachusetts General Laws Chapter 140, § 131 requires a license to carry (LTC) for concealed carry and a firearm identification (FID) card for possession of rifles and shotguns. Licensing authorities have historically denied LTCs to medical marijuana patients, and the state's may-issue regime gives chiefs nearly unlimited discretion. Following the Supreme Court ruling, the Massachusetts Executive Office of Public Safety issued guidance that marijuana use alone cannot be the basis for license denial, but chiefs may consider marijuana use as one factor in suitability determinations. This preserves substantial discretion and has led to continued denials in some jurisdictions, prompting litigation. Gun rights groups have filed suit in federal court arguing that Massachusetts's post-ruling approach violates both the Second Amendment and the marijuana-gun decision by allowing pretextual denials. The case is pending in the District of Massachusetts.

Market and Business Implications

The Supreme Court's decision unlocks significant market opportunities while creating new compliance challenges for the cannabis industry, firearms sector, and related service providers. The most immediate impact affects cannabis industry security. Dispensaries and cultivation facilities have operated under severe constraints, unable to employ armed security personnel who use cannabis products. The industry reported over $200 million in theft losses in 2025, with armed robberies targeting cash-intensive businesses that cannot access traditional banking due to federal restrictions under 31 U.S.C. § 5318. The National Cannabis Security Association estimates that 60-70% of security personnel in the cannabis industry use marijuana products, either recreationally or for medical purposes. Prior to the ruling, these individuals could not legally carry firearms, forcing businesses to choose between unarmed security or hiring non-users at premium wages. The ruling eliminates this constraint, allowing armed security by cannabis-using personnel and reducing insurance costs. Insurance markets are recalibrating risk models. Commercial general liability policies for cannabis businesses have carried premiums 200-300% higher than comparable retail businesses, partly due to robbery risk and lack of armed security. Underwriters anticipate premium reductions of 15-25% as armed security becomes more accessible, though this will vary by state and insurer. The firearms industry gains access to a massive new market. An estimated 55 million Americans live in adult-use legal states, and approximately 40% of U.S. households own firearms. The overlap represents millions of potential customers who previously faced legal barriers. The National Shooting Sports Foundation projects $500 million to $1 billion in new annual firearms sales as marijuana users enter or re-enter the legal market. Firearms training and education services are expanding offerings. Several national training organizations have announced cannabis-specific courses addressing responsible use, impairment recognition, and legal compliance. These courses target both individual gun owners and cannabis industry security personnel. Multi-state operators in the cannabis industry face complex compliance challenges. MSOs operating in multiple states must navigate varying state laws on firearms, security requirements, and marijuana regulations. The ruling creates opportunities for standardized armed security protocols but requires state-by-state legal analysis. Banking and financial services remain complicated. While the ruling resolves the gun rights issue, cannabis businesses still cannot access traditional banking due to federal money laundering and Bank Secrecy Act concerns. This perpetuates cash-intensive operations and the security vulnerabilities that armed personnel must address. The ruling may increase pressure on Congress to pass the SAFE Banking Act, which would provide safe harbor for financial institutions serving cannabis businesses. Real estate and property management sectors face new considerations. Landlords and property managers who lease to cannabis businesses have historically prohibited firearms on premises due to federal law concerns. The ruling eliminates the federal prohibition, but property owners retain authority to ban firearms through lease terms. Industry groups anticipate renegotiation of many commercial leases to address armed security. Employment law implications are significant. Employers in the cannabis industry have faced challenges with drug testing and firearms policies. Many security positions require firearm proficiency, but employers could not hire marijuana users. The ruling allows cannabis businesses to employ armed security who use marijuana, but employers must still address workplace impairment and safety concerns. Federal contractors and licensees face continued uncertainty. While the Supreme Court ruling protects Second Amendment rights, federal contractors (including firearms manufacturers with government contracts) remain subject to Drug-Free Workplace Act requirements. These employers may still prohibit marijuana use by employees, including those in positions requiring firearms. Capital markets and investment are affected. Cannabis industry investment has been constrained by federal illegality and associated risks. The ruling's recognition that marijuana occupies a unique legal status—state-legal, federally rescheduling, and now constitutionally protected for gun rights purposes—may signal to investors that federal prohibition is weakening. Several investment banks have upgraded cannabis sector ratings following the decision. Ancillary businesses serving the cannabis industry—